Aatmaja Healthcare Ltd

AATMAJHospital
22.00+0.00 (+0.00%)
As on 06 Feb 2026, 10:00 amMarket Closed

Fundamental Score

...

Aatmaja Healthcare Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

1.29%
Poor

Return on Capital Employed

3.39%
Excellent

Operating Profit Margin (5Y)

28.59%
Poor

Dividend Yield

0.00%

Valuation Metrics

Average

Price to Earnings

52.60x

Market Capitalization

44.18 (Cr)

Industry P/E

52.84x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

64.52%
Excellent

YoY Quarterly Sales Growth

27.03%
Excellent

Sales Growth (5Y)

35.94%
Excellent

EPS Growth (5Y)

16.45%
Excellent

Profit Growth (5Y)

34.31%

Financial Health

Excellent

Debt to Equity

0.22x
Poor

Interest Coverage

2.32x
Average

Free Cash Flow (5Y)

3.11 (Cr)

Ownership Structure

Good

Promoter Holding

63.76%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
63.76%
Promoter Holding
44.18 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of AATMAJ across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Operating Margins (28.59%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Robust Profit Growth (64.52%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (27.03%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (35.94% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Excellent EPS Growth (16.45% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (34.31% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Conservative Debt Levels (D/E: 0.22)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Balanced Promoter Holding (63.76%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

9 factors identified

Below-Average Return on Equity (1.29%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (3.39%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Premium Valuation Risk (P/E: 52.60x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Weak Interest Coverage (2.32x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Aatmaja Healthcare Ltd

About AATMAJ

Company Details

Symbol:AATMAJ
Industry:Hospital
Sector:Hospital
Website:N/A

AATMAJ Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)1.29%
Return on Capital Employed3.39%
Operating Profit Margin (5Y)28.59%
Debt to Equity Ratio0.22
Interest Coverage Ratio2.32

Growth & Valuation

Sales Growth (5Y)35.94%
Profit Growth (5Y)34.31%
EPS Growth (5Y)16.45%
YoY Quarterly Profit Growth64.52%
YoY Quarterly Sales Growth27.03%

Frequently Asked Questions

What is the current price of Aatmaja Healthcare Ltd (AATMAJ)?

As of 06 Feb 2026, 10:00 am IST, Aatmaja Healthcare Ltd (AATMAJ) is currently trading at ₹22.00. The stock has a market capitalization of ₹44.18 (Cr).

Is AATMAJ share price Overvalued or Undervalued?

AATMAJ is currently trading at a P/E ratio of 52.60x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Aatmaja Healthcare Ltd share price?

Key factors influencing AATMAJ's price include its quarterly earnings growth (Sales Growth: 27.03%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Aatmaja Healthcare Ltd a good stock for long-term investment?

Aatmaja Healthcare Ltd shows a 5-year Profit Growth of 34.31% and an ROE of 1.29%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.22 before investing.

How does Aatmaja Healthcare Ltd compare with its industry peers?

Aatmaja Healthcare Ltd competes with major peers in the Hospital. Investors should compare AATMAJ's P/E of 52.60x and ROE of 1.29% against the industry averages to determine its competitive standing.

What is the P/E ratio of AATMAJ and what does it mean?

AATMAJ has a P/E ratio of 52.60x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹53 for every ₹1 of annual earnings.

How is AATMAJ performing according to Bull Run's analysis?

AATMAJ has a Bull Run fundamental score of 63.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does AATMAJ belong to?

AATMAJ operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Aatmaja Healthcare Ltd.

What is Return on Equity (ROE) and why is it important for AATMAJ?

AATMAJ has an ROE of 1.29%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Aatmaja Healthcare Ltd generates profits from shareholders' equity.

How is AATMAJ's debt-to-equity ratio and what does it indicate?

AATMAJ has a debt-to-equity ratio of 0.22, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is AATMAJ's dividend yield and is it a good dividend stock?

AATMAJ offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has AATMAJ grown over the past 5 years?

AATMAJ has achieved 5-year growth rates of: Sales Growth 35.94%, Profit Growth 34.31%, and EPS Growth 16.45%.

What is the promoter holding in AATMAJ and why does it matter?

Promoters hold 63.76% of AATMAJ shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is AATMAJ's market capitalization category?

AATMAJ has a market capitalization of ₹44 crores, placing it in the Small-cap category.

How volatile is AATMAJ stock?

AATMAJ has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for AATMAJ?

AATMAJ has a 52-week high of ₹N/A and low of ₹N/A.

What is AATMAJ's operating profit margin trend?

AATMAJ has a 5-year average Operating Profit Margin (OPM) of 28.59%, indicating the company's operational efficiency.

How is AATMAJ's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 27.03% and YoY Profit Growth of 64.52%.

What is the institutional holding pattern in AATMAJ?

AATMAJ has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.